Ozempic’s FDA label warns that pancreatitis has been reported in medical trials and that individuals who expertise pancreatitis ought to completely cease utilizing the drug.
Nonetheless, knowledgeable consensus now could be that semaglutide and different GLP-1 medication don’t enhance the chance of pancreatitis, Drucker stated.
There’s a second drawback. GLP-1 medication could cause the discharge of enzymes related to pancreatic illness.
If a affected person tells their physician that they’ve belly ache (a typical facet impact of GLP-1 medication) and a blood or urine check reveals elevated ranges of amylase or lipase, “that is two of the three standards for pancreatitis,” Drucker says. Nonetheless, if GLP-1 is the plain trigger, an imaging scan of the pancreas shouldn’t be required to substantiate the prognosis, however could also be essential to rule out different causes.
“We’ve rather more knowledge now, and we do not actually see a noticeable enhance in pancreatitis with GLP-1 medication,” Drucker says.
Pancreatitis signs
In Ozempic’s official label, the FDA experiences that pancreatitis is characterised by “persistent, extreme belly ache, generally extending to the again, with or with out vomiting.” Different potential signs of pancreatitis embody fever, fast coronary heart price, and fatty or yellow stools.
Acute pancreatitis normally develops quickly and normally lasts only some days. This illness could require long-term hospitalization. In a small variety of circumstances, it will possibly result in severe penalties, together with demise.
Power pancreatitis, the place signs don’t enhance or maintain coming again, is mostly attributable to alcohol abuse.


